Launched in 2001, Lansing-based NovaSterilis develops supercritical CO2 terminal-sterilization processes, equipment, and testing services for sensitive medical products and materials. Its patented Nova Process was commercialized in 2007, and tissue sterilized through the process has been used in more than 500,000 surgeries worldwide. The company combines engineering and life-science expertise to help customers assess compatibility, develop processes, and move scCO2 solutions toward production and regulatory clearance.
EPA Green Chemistry Award
certification
FDA Challenge Grant I
compliance_program